Get Permission Munshi, Bohra, Mahindra, and Deshpande: Choriocarcinoma induced thyrotoxicosis


Introduction

Choriocarcinoma is a malignant disease arising from the placenta and trophoblastic villi. Gestational trophoblastic neoplasia (GTN) occur in 1 : 40,000 pregnancies and are more common in South East Asia as compared to Europe and North America.

Invasive mole and Choriocarcinoma are the most common GTN, producing high levels of HCG and are known to be responsive to chemotherapy.

HCG is used as a marker for diagnosis, monitoring the therapy and follow up of these patients. HCG is a glycoprotein produced by placenta and has an intrinsic thyroid stimulating activity. 1 Structural resemblance of TSH and HCG causes release of Thyroxine from the thyroid gland.

The first case of Hydatidiform mole and Thyrotoxicosis was reported in 1955 by Tisne and colleagues. 2

Since then several cases of Gestational trophoblastic disease induced Hyperthyroidism have been reported in literature. 3, 4, 5, 6, 7, 8

Case Presentation

A 25 year old female, diagnosed case of GTN (Choriocarcinoma) was admitted to our tertiary cancer care centre for chemotherapy and supportive care.

Case history

Patient was G2P0A1 (Obstretic score). She had history of one abortion more than a year back. No other details were available. She presented to us with complaints of pain in abdomen, bleeding per vaginum (PV) and breathlessness.

General examination

  1. General condition was moderate.

  2. Patient was afebrile.

  3. Pulse 142/min, BP 110/70,

  4. Respiratory rate 20/min,

  5. SpO2 98 % on room air.

Systemic examination

Cardiovascular(CVS) and Central Nervous System(CNS) examination were normal.

Radiological investigations

Revealed extensive bilateral metastatic nodules in lung Parenchyma (Figure 1).

PET CT revealed hypermetabolic, heterogeneously enhancing solid cystic mass lesion involving the uterus and cervix. (Site of primary malignancy) (Figure 1).

Figure 1

Radiological Investigations.

A):CT lung (Extensivebilateral metastatic nodules in lung parenchyma)

B):PET-CT(Hypermetabolic, heterogeneously enhancing solid cysticmass lesion involving the uterusand cervix. (Site of primary malignancy).

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/a1d0f955-cf76-457c-a54a-236a0cd80ce5/image/9ec1fbbe-6a5f-4ba3-a0be-c77acfc70a19-uimage.png

CT Brain

Normal. No evidence of metastasis.

Blood Investigations revealed: (Table 3)

  1. Serum Beta-HCG level was 6,88,748 mIu/ml (Normal range: 0 to 10 mIu/ml).

  2. Thyroid function tests showed Serum T3 to be 6.30 nmol/l (Normal range: 0.92 to 2.33 nmol/l).

  3. Serum T4 was 975 nmol/l (Normal range: 62 to 120 nmol/l).

  4. Serum TSH was less than 0.25 uIu/ml (Normal range: 0.25 to 5.00 uIu/ml).

Other Haematological and Biochemical parameters like Complete Blood Count(CBC), Kidney function tests (KFT) and liver function tests (LFT) were all within normal limits.

Diagnosis

Table 1

Prognostic scoring indexfor GTN (NCCN guidelines version 3.2020).

Prognostic Factor

Risk Score

0

1

2

4

Age ( Yrs)

< 40

≥ 40

-

-

Antecedent pregnancy

Hydatidi form mole

Abortion

Term Pregnancy

Interval from Index Pregnancy ( months)

< 4

4 to 6

7 to 12

> 12

Pretreatment HCG levels Iu/l

< 103

103 to < 104

104 to 105

≥ 105

Largest tumor size including uterus ( cm )

< 3

3 to 5

> 5

-

Site of Metasteses

Lung

Spleen,Kidney

GIT

Brain,Liver

No. of metastases identified

0

1 to 4

5 to 8

> 8

Previous Failed chemotherapy

-

-

Single drug

Two or more drugs

Total Score

12

[i] FIGO Score: Low risk < 7 , High Risk > 7

Table 2

BurchWartofsky point scale.

Temperature (℉)

Cardiovascular dysfunction

99-99.9

5 points

Tachycardia (beats/min)

100-100.9

10

99-109

5

101-101.9

15

110-119

10

102-102.9

20

120-129

15

103-103.9

25

130-139

20

≥104.0

30

≥140

25

Atrial fibrillation

10

Central Nervous System effects

Heart Failure

Absent

0

Mild (pedal edema)

5

Mild(agitation)

10

Moderate (bibasilar rales)

10

Moderate( delirium, psychosis, extreme lethargy)

20

Severe (pulmonary edema)

15

Severe (seizure, coma)

30

Gastrointestinal-hepatic dysfunction

Precipitant history

Moderate( diarrhea, nausea/vomiting, abdominal pain)

10

Positive

0

Severe (unexplained jaundice)

20

Negative

10

Total: <25, storm unlikely, 25-45, impending storm, >45, thyroid storm

Patients Score 35 Impending thyroid storm (Table 2)

Final Diagnosis: Gestational trophoblastic neoplasm (Chorio carcinoma, High Risk FIGO grade III).

(Table 1) with pulmonary metastases and hyperthyroidism (Impending Thyroid storm) ( Table 2).

Treatment aspect

Chemotherapy was started: EMACO Day 1 and Day 8, 6 cycles.

Patient had Biochemical as well as Clinical Hyperthyroidism. Burch- Wartofsky score for patient was 35 which indicated impending thyroid storm. (Table 2)

Patient was put on Neomercazol 5 mg BD. Other supportive care was initiated.

Patients Beta-HCG levels were monitored weekly. There was marked decline in serum BHCG levels. At one month, Beta-HCG was 711 mIu/ml and Thyroid function normalized. T3 was 2.0 nmol/l, T4 was 101 nmol/l and TSH was 1.80 uIu/ml. (Table 3)

Patient’s Anti thyroid medication i.e Neomercazol was stopped. Patient was monitored on monthly basis for serum B HCG levels. At one year follow up, Patients Beta-HCG level was 0.3 mIu/ml.

Patient was Euthyroid without any anti thyroid medication and doing well.

Table 3

Summary of HCG, TFT measurements.

Test

Ref.Value s

At presentation

One month

Six months

One year

B-HCG

0 to 10 mIu/ml

6,88,748

711

130

0.3

TSH

0.25 to 5.00 uIu/ml

Less than 0.25

1.80

1.14

T3

0.92 to 2.33 nmol/l

6.30

2.00

1.2

T4

62 to 120 nmol/l

975

101

66

F T3

2.30 to 4.20 pg/ml

3.26

F T4

0.89 to 1.76 ng/dl

0.81

Neomercazole

Neomercazol e 5 mg BD

Neomarcazol e 5mg BD

Without Neomercazol e

Without Neomercazol e

Discussion

Choriocarcinoma is the most aggressive form of GTN, characterized by vascular invasion and wide spread metastases. The most common metastatic sites are lung (80 % ), vagina ( 30 % ) brain ( 10 % ) and liver ( 10 % ). 9

The pathophysiology of thyroid disease in GTN is related to the secretion of HCG from the trophoblastic tissue. The effect of HCG on thyroid gland is thought to occur due to molecular mimicry between HCG and TSH.

The two known mechanisms are increased thyrotropic activity by HCG and structural resemblance with TSH causing release of thyroxine from thyroid gland. 10

Cave and colleagues11 examined serum from patients with metastatic choriocarcinoma. By using gel filtration, a single peak coinciding with HCG was demonstrated. This suggested that the thyrotropin of choriocarcinoma was HCG. The similarity in structure between HCG and TSH can cause cross reactivity of each receptor.

Various studies have shown prevalence of hyperthyroidism with high levels of HCG. Lockwood et al. found suppressed TSH in 100 % specimen with HCG concentration > 40,000 Iu/l. 12 Glinoer estimated that any increase 10,000 Iu/l for HCG will be followed by increase in FT4 by

ng/dl and reduction in TSH by 0.1 mIu/ml. 13, 14, 15

Although there is no precise threshold at which HCG causes Thyrotoxicosis, thyroid function should be measured in all patients with HCG > 50,000 Iu/L regardless of the cause of elevation. 16, 17

Choriocarcinoma is sensitive to chemotherapy and choice of regimen is based on WHO (World Health Organisation)Prognostic Scoring System and the International Federation of Gynecology and Obstetrics( FIGO) anatomic staging system.

In patients having Biochemical and Clinical Hyperthyroidism, Burch- Wartofsky score should be assessed for presence of Thyroid storm and treatment should be initiated accordingly. Unless there are symptoms of severe thyrotoxicosis, treatment of hyperthyroidism is not needed, as chemotherapy for Choriocarcinoma should effectively bring down the HCG levels alleviating the hyperthyroidism.

Conclusion

  1. Choriocarcinoma is not only associated with Hyperthyroidism , but also can induce thyroid storm.

  2. GTD induced thyroid storm should be considered in any female of child bearing age with signs and symptoms of Thyrotoxicosis.

  3. High levels of HCG are directly proportional to the clinical manifestation of Hyperthyroidism.

  4. Thyroid function must be measured in all patients with HCG levels > 50,000Iu/L.

  5. In patients having Biochemical and clinical hyperthyroidism, Burch- Wartofsky score should be assessed for presence of Thyroid storm and treatment should be initiated accordingly.

  6. Unless there are symptoms of severe thyrotoxicosis, Treatment of hyperthyroidism is not initiated.

  7. Thyroid function is expected to return to normal once the HCG levels come down.

  8. Awareness of this condition is important for diagnosis and treatment of GTD.

  9. GTD induced thyroid storm should be considered in any female of child bearing age with signs and symptoms of thyrotoxicosis.

Source of Funding

None.

Conflict of Interest

None.

References

1 

HJ Clain PR Pannall D Kotasek RJ Norman Choriogonadotropin-mediated thyrotoxicosis in a manClin Chem1991376112731

2 

L Tisne J Barzelatto C Stevenson Am J Pathol Estudio de function tireoldeaduranteelestado gravid- puerperalconelyodoradioactivoBot S195520246

3 

BC Nisula GS Taliadouros Thyroid function in gestational tropho- blastic neoplasia: Evidence that the thyrotropic activity of chorionic gona- dotropin mediates the thyrotoxicosis of choriocarcinomaAm J Obstet Gynecol 198013817785

4 

WP Myers An analysis of medical problems in cancerMed Clin North Am19614556383

5 

JD Cohen RD Utiger Metastatic choriocarcinoma associated with hyperthyroidismJ Clin Endocrinol Metab 19703044239

6 

JE Morley RJ Jacobson J Melamed JM Hershman .1 Choriocarcinoma as a cause of thyrotoxicosisAm J Med1976607103640

7 

WD Odell RW Bates RS Rivlin Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinomaJ Clin Endocrinol Metab19632365864

8 

K Miyai O Tanizawa T Yamoto M Azukizawa Y Kawai Pituitary-thyroid function in trophoblastic diseaseJ Clin Endocrinol Metab 19764222549

9 

G Zanetta R Maggi M Colombo G Bratina C Mangioni Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literatureInt J Gynecol Cancer1997716677

10 

JVB Pereira T Lim Hyperthyroidism in gestational trophoblastic disease-a literature reviewThyroid Res20211411

11 

WT Cave JT Dunn Choriocarcinoma with hyperthyroidism: Probable identity of the thyrotropin with human chorionic gonadotropinAnn Intern Med1976851603

12 

CM Lockwood DG Grenache AM Gronowski Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrationsThyroid20091988638

13 

DS Cooper LE Braverman Trophoblastic tumor in Werner Ingbar's. The thyroid: A fundamental and clinical textPhiladelphia, Lippincott Williams Wilkins201340913

14 

Lhf Meister PR Hauck H Graf GA Carvalho Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinomaArq Bras Endocrinol Metabol200549231922

15 

L Walkington J Webster BW Hancock J Everard RE Coleman Hyperthyroidism and human chorionic gonadotropin in gestational trophoblastic diseaseBr J Cancer20111041116659

16 

SF Oosting ECD Hass TP Links DD Bruin WJ Sluiter IJD Jong Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumorsAnn Oncol20102111048

17 

P Heda G Cushing Testicular choriocarcinoma presenting as hyperthyroidismAm J Med20131261112



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 03-10-2024

Accepted : 08-11-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/ 10.18231/j.jdpo.2024.052


Article Metrics






Article Access statistics

Viewed: 231

PDF Downloaded: 57